Ho Tony
Mount Elizabeth Medical Centre, Singapore 228510, Singapore.
J Clin Med. 2024 May 23;13(11):3058. doi: 10.3390/jcm13113058.
: To evaluate the safety and efficacy of the transepithelial photorefractive keratectomy (TransPRK) performed using smart pulse technology (SPT) in myopic eyes with refractive error ranging from -5.25 D to -9.75 D. : This retrospective study evaluated the outcomes of SPT-assisted TransPRK in 150 eyes performed using a 1050 Hz AMARIS excimer laser. : At 6 months postoperative, 98% of eyes achieved uncorrected distance visual acuity (UDVA) of 20/25 or better, and postoperative UDVA within one line of preoperative corrected distance visual acuity (CDVA). No eyes lost any line of CDVA. Residual spherical equivalent refraction and cylinder within ±0.50 D of intended correction were achieved in 72% and 67% of eyes, respectively. Ninety-seven percent of eyes reported no halos and glare. : TransPRK using a 1050 Hz excimer laser with SPT showed excellent predictability, safety, and efficacy for moderate to high myopia correction.
评估使用智能脉冲技术（SPT）进行的经上皮准分子激光角膜切削术（TransPRK）在近视度数为-5.25 D至-9.75 D的近视眼中的安全性和有效性。：这项回顾性研究评估了使用1050 Hz阿玛里斯准分子激光对150只眼睛进行SPT辅助TransPRK的结果。：术后6个月时，98%的眼睛裸眼远视力（UDVA）达到20/25或更好，且术后UDVA与术前矫正远视力（CDVA）相差不超过一行。没有眼睛的CDVA下降。分别有72%和67%的眼睛残余球镜等效屈光度和柱镜度在预期矫正值的±0.50 D范围内。97%的眼睛报告无光晕和眩光。：使用1050 Hz准分子激光和SPT的TransPRK在中高度近视矫正方面显示出优异的可预测性、安全性和有效性。
